References
- Neuschwander-Tetri BA. Evolving pathophysiologic concepts in non-alcoholic steatohepatitis. Curr Gastroenterol Rep. 2002; 4: 31–6.
- Gupta S, Slaughter S, Akriviadis EA, Valenzuela R, Deodhar SD. Serial measurement of serum C-reactive protein facilitates evaluation in alcoholic hepatitis. Hepatogastroenterology. 1995; 42: 516–21.
- Shiota G, Umeki K, Okano J, Kawasaki H. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases. J Med. 1995; 26: 295–308.
- Shima M, Nakao K, Kato Y, Nakata K, Ishii N, Nagataki S. Comparative study of C-reactive protein in chronic hepatitis B and chronic hepatitis C. Tohoku J Exp Med. 1996; 178: 287–97.
- Bell H, Skinningsrud A, Raknerud N, Try K. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver disease. J Intern Med. 1994; 236: 315–22.
- Bacon B, Farahvash M, Janney C, Neuschwander-Tetri B. Non-alcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 1994; 107: 1103–9.
- George DK, Goldwurm S, McDonald GA, Cowley LL, Walker NI, Ward PJ, et al.. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology. 1998; 114: 311–8.
- Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet. 1997; 349: 95–7.
- Mendler MH, Turlin B, Moirand R, Jouanolle A-M, Sapey T, Guyader D, et al.. Insulin resistance-associated hepatic iron overload. Gastroenterology. 1999; 117: 1155–63.
- Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, et al.. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for non-alcoholic steatohepatitis. Am J Gastroenterol. 2001; 96: 2448–54.
- Gerok W, Gross V. Protein secretion, degradation and function. Oxford textbook of clinical hepatology2nd ed. Bircher J, Benhamou JP, Mclntyre N, Rizetto M, Rodes JOxford University Press. New York, 1999; 1: 346–67.
- Tuck CH, Holleran S, Berglund L. Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein (a) and acute phase reactants in postmenopausal women. Arterioscler Thromb Biol. 1997; 17: 1822–9.
- Min WK, Chun S, Hwang SH, Park H. No relationship between serum lipoprotein(a) and albumin concentrations in patients with acute phase response. Ann Clin Biochem. 1999; 36: 617–21.